Search by Drug Name or NDC

    NDC 71610-0058-65 SENEXON 8.6 mg/1 Details

    SENEXON 8.6 mg/1

    SENEXON is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is SENNOSIDES A AND B.

    Product Information

    NDC 71610-0058
    Product ID 71610-058_81c8d20a-3679-423a-8916-a1e5dcde0fbf
    Associated GPIs 46200060200303
    GCN Sequence Number 019964
    GCN Sequence Number Description sennosides TABLET 8.6 MG ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 00701
    HICL Sequence Number 001289
    HICL Sequence Number Description SENNOSIDES
    Brand/Generic Generic
    Proprietary Name SENEXON
    Proprietary Name Suffix n/a
    Non-Proprietary Name SENNA
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 8.6
    Active Ingredient Units mg/1
    Substance Name SENNOSIDES A AND B
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part334
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0058-65 (71610005865)

    NDC Package Code 71610-058-65
    Billing NDC 71610005865
    Package 100 TABLET, COATED in 1 BOTTLE, PLASTIC (71610-058-65)
    Marketing Start Date 2018-05-04
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 18c77552-9e65-4e73-9e41-59f91075ce94 Details

    Revised: 5/2018